SAKAR HEALTHCARE
|
The Current P/S Ratio of SAKAR HEALTHCARE is 3.87.
Share Price | ₹313.7 | Jun 05,2025 |
Market Cap | ₹686.9 Cr | |
Sales-TTM | ₹177.6 Cr | TTM-Consolidated Results |
Price/Sales | 3.87x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SAKAR HEALTHCARE
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹686.9 Cr] as on Jun 05,2025
(/) Sales [ ₹177.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.87x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay '3.87 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SAKAR HEALTHCARE !
The chart below summarizes the trend in P/S Ratio of SAKAR HEALTHCARE over the last five years.
Historical PS (Price/Sales) ratio chart of SAKAR HEALTHCARE
PS Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 1.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 5.22x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 0.9x.
How does SAKAR HEALTHCARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SAKAR HEALTHCARE | 177.6 | 3.87 | 686.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.68 | 403,868.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.80 | 176,010.0 |
CIPLA LTD | 27,547.6 | 4.37 | 120,318.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.24 | 106,406.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.30 | 107,644.0 |
MANKIND PHARMA LTD | 12,279.3 | 7.94 | 97,442.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.14 | 96,155.7 |
LUPIN LTD | 22,707.9 | 4.01 | 91,124.5 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.12 | 67,344.0 |
ABBOTT INDIA LTD | 6,409.2 | 10.51 | 67,360.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAKAR HEALTHCARE 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.12x |
Max industry PS | 18.80x |
Median industry PS | 4.37x |
Average industry PS | 6.91x |
You may also like the below Video Courses